Future of the drug label: perspectives from a multi stakeholder dialogue
Publication date
2019-07-18
Authors
Gispen-de Wied, C.C.
Weemers, J.
Boon, W.P.C.
Mol, P.G.M.
Stolk, P.
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
'Regulating drugs does not end when market access has been granted. Monitoring drugs over the life-cycle has become state of the art, inherent to evolving legislation and societal need. Here, we explore how the drug label could move along in a changing playing-field, and become a sustainable label for the future. A dialogue between academia, government, the pharmaceutical industry, and patient/societal organizations was organized by the Regulatory Science Network Netherlands, RSNN. This is their view.'
Keywords
label, regulatory authorities, SmPC, adult, article, drug industry, government, human, Netherlands, organization
Citation
Gispen-de Wied, C C, Weemers, J, Boon, W, Mol, P G M & Stolk, P 2019, 'Future of the drug label : perspectives from a multi stakeholder dialogue', British Journal of Clinical Pharmacology, vol. 85, no. 10, pp. 2442-2445. https://doi.org/10.1111/bcp.14070